VBC VERTEX BIOPHARM CONSULTING Trademark

Trademark Overview


On Wednesday, December 31, 2025, a trademark application was filed for VBC VERTEX BIOPHARM CONSULTING with the United States Patent and Trademark Office. The USPTO has given the VBC VERTEX BIOPHARM CONSULTING trademark a serial number of 99573669. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, December 31, 2025. This trademark is owned by Vertex BioPharm Consulting. The VBC VERTEX BIOPHARM CONSULTING trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Consulting services in the field of biotechnology; Biotechnology research; Research and development in the field of biotechnology; Research and development in the pharmaceutical and biotechnology fields; Research and development services in the field of biotechnology; Testing of computer software; Technical consulting in the field of pharmaceutical studies; Computer programming; Consulting services in the fields of selection, implementation and use of computer hardware and software systems for others; Chemical laboratories; Genetic testing for scientific research purposes; Scientific research; Medical research; Medical and scientific research, namely, conducting clinical trials for others; Data automation and collection service using proprietary software to evaluate, analyze and collect service data; Research on the subject of pharmaceuticals; Conducting early evaluations in the field of new pharmaceuticals; Pharmaceutical product evaluation; Consultancy in the field of software design
vbc vertex biopharm consulting

General Information


Serial Number99573669
Word MarkVBC VERTEX BIOPHARM CONSULTING
Filing DateWednesday, December 31, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, December 31, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesConsulting services in the field of biotechnology; Biotechnology research; Research and development in the field of biotechnology; Research and development in the pharmaceutical and biotechnology fields; Research and development services in the field of biotechnology; Testing of computer software; Technical consulting in the field of pharmaceutical studies; Computer programming; Consulting services in the fields of selection, implementation and use of computer hardware and software systems for others; Chemical laboratories; Genetic testing for scientific research purposes; Scientific research; Medical research; Medical and scientific research, namely, conducting clinical trials for others; Data automation and collection service using proprietary software to evaluate, analyze and collect service data; Research on the subject of pharmaceuticals; Conducting early evaluations in the field of new pharmaceuticals; Pharmaceutical product evaluation; Consultancy in the field of software design
Description of MarkThe mark consists of The letter, "VERTEX BIOPHARM CONSULTING", is "black". The Letter, "VBC", is "purple" and "night blue".
Indication of Colors claimedThe color(s) Black, Green, Purple, Night Blue is/are claimed as a feature of the mark.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 31, 2025
Primary Code042
First Use Anywhere DateWednesday, December 31, 2025
First Use In Commerce DateWednesday, December 31, 2025

Trademark Owner History


Party NameVertex BioPharm Consulting
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressZurich, VA 22101

Trademark Events


Event DateEvent Description
Wednesday, December 31, 2025NEW APPLICATION ENTERED
Wednesday, December 31, 2025APPLICATION FILING RECEIPT MAILED